Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and vibrators.
Popular Articles

Senate Confirms Goosby As U.S. Global AIDS Coordinator
The Senate on Friday confirmed President Obama"s U.S. Global AIDS Coordinator nominee Eric Goosby, the San Francisco Chronicle reports. Goosby - who "served previously in the Clinton administration as director of HIV/AIDS policy in the Department of Health and Human Services and as chief adviser to the president on HIV-related issues" - will now "head the U.S. strategy for addressing HIV around the world, and oversee the implementation of the President"s Emergency Plan for AIDS Relief" (PEPFAR), the newspaper writes. Goosby "has more than 25 years of experience treating HIV/AIDS," and most recently served as chief executive officer and chief medical officer of the Pangaea Global AIDS Foundation, which is affiliated with the San Francisco AIDS Foundation, according to the San Francisco Chronicle (Doyle, San Francisco Chronicle, 6/20).
buy viagra
Brain Irradiation In Lung Cancer
A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.
News of the day
New Internet Intervention Gives Insomnia Patients A Better Night's Sleep
The estimated one-third of adults who suffer from insomnia could soon find effective treatment without ever leaving their homes. Researchers at the University of Virginia Health System have developed a unique Internet-based intervention, based on well-established face-to-face cognitive behavioral therapy techniques, that has shown remarkable results in improving patients" sleep.
Sexual Health

Common Antibiotics May Be Best First Treatment For Children With MRSA-related Infections

Penicillin and other antibiotics in the beta-lactam family work as well as other antibiotics to treat MRSA (methicillin-resistant Staphylococcuss aureus) infections in the skin and soft-tissue of children and may help prevent further resistance to antibiotic treatment, according to a new study funded by the Agency for Healthcare Research and Quality. The study, published in the June, 2009 issue of Pediatrics, compared treatment outcomes for three different antibiotics beta-lactums (which include penicillin, cephalosporins, carbapenems and monobactams), clindamycin, and trimethoprim-sulfamethoxazole (TMP -SMZ). The study concluded that children treated with clindamycin for skin and soft tissue infections potentially caused by MRSA did not show greater improvement compared to those treated with beta-lactam therapy. Children treated with TMP-SMZ were less likely to show improvement. Among the study"s findings: -- Beta- lactams may still be the best first line initial therapy for skin and soft tissue infections possibly caused by MRSA. -- Community- Acquired MRSA may not be the cause of skin and soft tissue infections even when MRSA is prevalent. -- The use of beta-lactams may help prevent further resistance to antibiotic treatment of skin and tissue infections. -- Beta-lactam therapy is more palatable to children than clindamycin because it is not associated with side effects, such as nausea and mild diarrhea. It is also not as expensive as other treatments. The authors of this study recommend further research to establish a higher level of evidence and to confirm study results. This study was funded by a cooperative agreement through an AHRQ grant to the Centers for Education and Research on Therapeutics (CERTs) research network, which is part of the agency"s Effective Health Care Program. The Effective Health Care Program sponsors the development of new scientific knowledge through studies on the outcomes of health care technologies and services. AHRQ


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009